Literature DB >> 11733492

Crystal structure of the extracellular domain of mouse RANK ligand at 2.2-A resolution.

Shuichiro Ito1, Kenji Wakabayashi, Osamu Ubukata, Shinko Hayashi, Fumihiko Okada, Tadashi Hata.   

Abstract

Bone remodeling involves the resorption of bone by osteoclasts and the synthesis of bone matrix by osteoblasts. Receptor activator of NF-kappa B ligand (RANKL, also known as ODF and OPGL), a member of the tumor necrosis factor (TNF) family, triggers osteoclastogenesis by forming a complex with its receptor, RANK. We have determined the crystal structure of the extracellular domain of mouse RANKL at 2.2-A resolution. The structure reveals that the RANKL extracellular domain is trimeric, which was also shown by analytical ultracentrifugation, and each subunit has a beta-strand jellyroll topology like the other members of the TNF family. A comparison of RANKL with TNF beta and TNF-related apoptosis-inducing ligand (TRAIL), whose structures were determined to be in the complex form with their respective receptor, reveals conserved and specific features of RANKL in the TNF superfamily and suggests the presence of key residues of RANKL for receptor binding.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733492     DOI: 10.1074/jbc.M106525200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Crystallization and preliminary X-ray analysis of mouse RANK and its complex with RANKL.

Authors:  Thomas S Walter; Changzhen Liu; Peng Huang; Shiqian Zhang; Lucy R Wedderburn; Bin Gao; Raymond J Owens; David I Stuart; Peifu Tang; Jingshan Ren
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-05-22

2.  A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss.

Authors:  Kazuhiro Aoki; Hiroaki Saito; Cecile Itzstein; Masaji Ishiguro; Tatsuya Shibata; Roland Blanque; Anower Hussain Mian; Mariko Takahashi; Yoshifumi Suzuki; Masako Yoshimatsu; Akira Yamaguchi; Pierre Deprez; Patrick Mollat; Ramachandran Murali; Keiichi Ohya; William C Horne; Roland Baron
Journal:  J Clin Invest       Date:  2006-05-04       Impact factor: 14.808

3.  Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis.

Authors:  Hai Minh Ta; Giang Thi Tuyet Nguyen; Hye Mi Jin; Jongkeun Choi; Hyejin Park; Nacksung Kim; Hye-Yeon Hwang; Kyeong Kyu Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

4.  RANKL employs distinct binding modes to engage RANK and the osteoprotegerin decoy receptor.

Authors:  Christopher A Nelson; Julia T Warren; Michael W-H Wang; Steven L Teitelbaum; Daved H Fremont
Journal:  Structure       Date:  2012-10-02       Impact factor: 5.006

5.  Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: influence of osteotropic factors.

Authors:  Steeve Kwan Tat; Jean-Pierre Pelletier; Daniel Lajeunesse; Hassan Fahmi; Nicolas Duval; Johanne Martel-Pelletier
Journal:  Bone       Date:  2008-04-26       Impact factor: 4.398

6.  Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival.

Authors:  Marc Baud'huin; Laurence Duplomb; Stéphane Téletchéa; Céline Charrier; Mike Maillasson; Marc Fouassier; Dominique Heymann
Journal:  J Biol Chem       Date:  2009-09-16       Impact factor: 5.157

7.  Mutations within the TNF-like core domain of RANKL impair osteoclast differentiation and activation.

Authors:  Taksum Cheng; Nathan J Pavlos; Cathy Wang; Jamie We-Yin Tan; Jian Ming Lin; Jillian Cornish; Ming-Hao Zheng; Jiake Xu
Journal:  Mol Endocrinol       Date:  2008-11-13

8.  A comprehensive manually curated reaction map of RANKL/RANK-signaling pathway.

Authors:  Rajesh Raju; Lavanya Balakrishnan; Vishalakshi Nanjappa; Mitali Bhattacharjee; Derese Getnet; Babylakshmi Muthusamy; Joji Kurian Thomas; Jyoti Sharma; B Abdul Rahiman; H C Harsha; Subramanian Shankar; T S Keshava Prasad; S Sujatha Mohan; Gary D Bader; Mohan R Wani; Akhilesh Pandey
Journal:  Database (Oxford)       Date:  2011-07-08       Impact factor: 3.451

Review 9.  Principles of antibody-mediated TNF receptor activation.

Authors:  H Wajant
Journal:  Cell Death Differ       Date:  2015-08-21       Impact factor: 15.828

Review 10.  RANKL cytokine: from pioneer of the osteoimmunology era to cure for a rare disease.

Authors:  Nadia Lo Iacono; Alessandra Pangrazio; Mario Abinun; Robbert Bredius; Marco Zecca; Harry C Blair; Paolo Vezzoni; Anna Villa; Cristina Sobacchi
Journal:  Clin Dev Immunol       Date:  2013-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.